Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea

Archives of Internal Medicine

Volumn 166, Issue 9, 2006, Pages 977-984

  Ayas, Najib T ^a,b,c   FitzGerald, J Mark ^a,c   Fleetham, John A ^a,b   White, David P ^e   Schulzer, Michael ^c   Ryan, C Frank ^a,b   Ghaeli, Reza ^d   Mercer, G William ^a   Cooper, Peter ^d   Tan, Michael C Y ^c   Marra, Carlo A ^a,c,f  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Vancouver Acute Hospitals   (Canada)

^c VANCOUVER COASTAL HEALTH RESEARCH INSTITUTE   (Canada)

^d Insurance Corporation of British Columbia   (Canada)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; QUALITY OF LIFE; SENSITIVITY ANALYSIS; SLEEP APNEA SYNDROME; TRAFFIC ACCIDENT;

EID: 33646412040     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.166.9.977     Document Type: Article

References (46)

1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230-1235.
2. Flemons WW. Obstructive sleep apnea. N Engl J Med. 2002;347:498-504.
3. Teran-Santos J, Jimenez-Gomez A, Cordero-Guevara J; Cooperative Group Burgus-Santander. The association between sleep apnea and the risk of traffic accidents. N Engl J Med. 1999;340:847-851.
4. Patel SR, White DP, Malhotra A, Stanchina M, Ayas NT. The effect of CPAP therapy on subjective and objective sleepiness in obstructive sleep apnea: a metaanalysis of randomized controlled trials. Arch Intern Med. 2003;163:565-571.
5. Malhotra A, Ayas N, Epstein L. The art and science of continuous positive airway pressure therapy in obstructive sleep apnea. Curr Opin Pulm Med. 2000;6:490-495.
6. George CF. Reduction in motor vehicle collisions following treatment of sleep apnoea with nasal CPAP. Thorax. 2001;56:508-512.
7. Hirth RA, Chernew ME, Miller E, et al. Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making. 2000;20:332-342.
8. Ubel PA, Hirth RA, Chernew ME, Fendrick AM. What is the price of life and why doesn't it increase at the rate of inflation? Arch Intern Med. 2003;163:1637-1641.
9. Chakravorty I, Cayton RM, Szczepura A. Health utilities in evaluating intervention in the sleep apnoea/hypopneoea syndrome. Eur Respir J. 2002;20:1233-1238.
10. Graham JD, Thompson KM, Goldie SJ, Segui-Gomez M, Weinstein MC. The cost-effectiveness of air bags by seating position. JAMA. 1997;278:1418-1425.
11. Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in Health and Medicine. New York, NY: Oxford University Press Inc; 1996.
12. McArdle N, Devereux G, Heidarnejad H, Engleman HM, Mackay TW, Douglas NJ. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 1999;159:1108-1114.
13. Findley L, Smith C, Hooper J, Dineen M, Suratt PM. Treatment with nasal CPAP decreases automobile accidents in patients with sleep apnea. Am J Respir Crit Care Med. 2000;161:857-859.
14. Krieger J, Meslier N, Lebrun T, et al. Accidents in obstructive sleep apnea patients treated with nasal continuous positive airway pressure: a prospective study. Chest. 1997;112:1561-1566.
15. Engleman HM, Asgari-Jirhandeh N, McLeod AL, Ramsay CF, Deary IJ, Douglas NJ. Self-reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest. 1996;109:1470-1476.
16. Horstmann S, Hess CW, Bassetti C, Gugger M, Mathis J. Sleepiness-related accidents in sleep apnea patients. Sleep. 2000;23:383-389.
17. Cassel W, Ploch T, Becker C, Dugnus D, Peter JH, von Wichert P. Risk of traffic accidents in patients with sleep-disordered breathing: reduction with nasal CPAP. Eur Respir J. 1996;9:2606-2611.
18. Yamamoto H, Akashiba T, Kosaka N, Ito D, Horie T. Long-term effects of nasal continuous positive airway pressure on daytime sleepiness, mood and traffic accidents in patients with obstructive sleep apnoea. Respir Med. 2000;94:87-90.
19. Suratt P, Findley L. Effect of nasal CPAP treatment on automobile driving simulator performance and on self-reported automobile accidents in subjects with sleep apnea [abstract]. Am Rev Respir Dis. 1992;145:A169.
20. Borgel J, Sanner BM, Keskin F, et al. Obstructive sleep apnea and blood pressure: interaction between the blood pressure-lowering effects of positive airway pressure therapy and antihypertensive drugs. Am J Hypertens. 2004;17:1081-1087.
21. Rowley JA, Aboussouan LS, Badr MS. The use of clinical prediction formulas in the evaluation of obstructive sleep apnea. Sleep. 2000;23:929-938.
22. Traffic safety facts 2003. National Highway Traffic Safety Administration, National Center for Statistics and Analysis, US Dept of Transportation, Washington, DC, October 2004. Available at: http://www-nrd. nhtsa.dot.gov/pdf/nrd-30/NCSA/TSFAnn/2003/TSF2003-Early.htm#chap4. Accessed July 15, 2005.
23. Blincoe L, Seay A, Zaloshnja E, Millar T, Romano E, Luchter S, Spicer R. The Economic Impact of Motor Vehicle Crashes. Washington, DC: US Dept of Transportation, National Highway Traffic Safety Administration; May 2002.
24. United States life tables. National Center for Health Statistics, US Department of Health and Human Services, Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/nchs/products/pubs/pubd/lftbls/ lftbls.htm. Accessed June 17, 2005.
25. Neumann PJ, Goldie SJ, Weinstein MC. Preference-based measures in economic evaluation in health care. Annu Rev Public Health. 2000;21:587-611.
26. Drummond MF, O'Brien B, Stoddart GL, Torrance GW, eds. Methods for the Economic Evaluation of Health Care Programmes. 2nd ed. Oxford, England: Oxford Medical Publications; 1997.
27. Tousignant P, Cosio MG, Levy RD, Groome PA. Quality adjusted life years added by treatment of obstructive sleep apnea. Sleep. 1994;17:52-60.
28. Mar J, Rueda JR, Duran-Cantolla J, Schechter C, Chilcott J. The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea. Eur Respir J. 2003;21:515-522.
29. Jenkinson C, Stradling J, Petersen S. How should we evaluate health status? a comparison of three methods in patients presenting with obstructive sleep apnoea. Qual Life Res. 1998;7:95-100.
30. MacKenzie EJ, Damiano A, Miller T, Luchter S. The development of the Functional Capacity Index. J Trauma. 1996;41:799-807.
31. Prosser LA, Stinnett AA, Goldman PA, et al. Cost-effectiveness of cholesterollowering therapies according to selected patient characteristics. Ann Intern Med. 2000;132:769-779.
32. Wong JB. Cost-effectiveness of anti-tumor necrosis factor agents. Clin Exp Rheumatol. 2004;22(suppl 35):S65-S70.
33. Ramsey SD, Berry K, Etzioni R, Kaplan RM, Sullivan SD, Wood DE; National Emphysema Treatment Trial Research Group. Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema. N Engl J Med. 2003;348:2092-2102.
34. Scharf MB, Stover R, McDannold MD, Spinner O, Berkowitz DV, Conrad C. Outcome evaluation of long-term nasal continuous positive airway pressure therapy in obstructive sleep apnea. Am J Ther. 1999;6:293-297.
35. Ulfberg J, Carter N, Edling C. Sleep-disordered breathing and occupational accidents. Scand J Work Environ Health. 2000;26:237-242.
36. Otake K, Delaive K, Walld R, Manfreda J, Kryger MH. Cardiovascular medication use in patients with undiagnosed obstructive sleep apnoea. Thorax. 2002;57:417-422.
37. Parish JM, Lyng PJ. Quality of life in bed partners of patients with obstructive sleep apnea or hypopnea after treatment with continuous positive airway pressure. Chest. 2003;124:942-947.
38. Montserrat JM, Barbe F, Rodenstein DO. Should all sleep apnoea patients be treated? Sleep Med Rev. 2002;6:7-14.
39. Barbe F, Mayoralas LR, Duran J, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness: a randomized, controlled trial. Ann Intern Med. 2001;134:1015-1023.
40. Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med. 2002;166:159-165.
41. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365:1046-1053.
42. Ip MS, Tsh HF, Lam B, Tsang KW, Lam WK. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med. 2004;169:348-353.
43. Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation. 2003;107:1129-1134.
44. Faccenda JF, Mackay TW, Boon NA, Douglas NJ. Randomized placebocontrolled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med. 2001;163:344-348.
45. Barcelo A, Barbe F, Llompart E, et al. Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea. Am J Med. 2004;117:118-121.
46. Sassani A, Findley LJ, Kryger M, Goldlust E, George C, Davidson TM. Reducing motor-vehicle collisions, costs, and fatalities by treating obstructive sleep apnea syndrome. Sleep. 2004;27:453-458.